ClinicalTrials.gg
Not yet recruitingNCT07868380Updated Oct 13, 2026

Effects of Two Swaddling Techniques on Infant Sleep, Crying, and Maternal Comfort

An interventional study of Hip-Healthy Swaddling and Midline Flexion Swaddling in Infant Sleep and Crying, sponsored by Izmir University of Economics. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 1 Month to 4 Months. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Izmir University of Economics · Not applicable, Interventional, and Supportive care

Updated Oct 9, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
1 Month to 4 Months
Sex
All
01

Study summary

The goal of this clinical trial is to learn how two different safe swaddling techniques affect sleep duration, crying duration, and maternal comfort in infants aged 1-4 months and their mothers. The main questions it aims to answer are:

  • Do hip-healthy swaddling and midline flexion swaddling affect infants' sleep duration compared with routine care without a study-assigned swaddling intervention?
  • Do hip-healthy swaddling and midline flexion swaddling affect infants' crying duration compared with routine care without a study-assigned swaddling intervention?
  • Do the two swaddling techniques affect mothers' comfort levels compared with routine care? Researchers will compare three groups: hip-healthy swaddling, midline flexion swaddling, and a control group receiving routine care without a study-assigned swaddling intervention. This will help determine whether the two swaddling techniques have different effects on infant sleep and crying duration and maternal comfort.

Mothers and infants participating in the study will:

  • Be randomly assigned to one of the three study groups.
  • Receive face-to-face training, an educational brochure, and an instructional video on the assigned swaddling technique if allocated to one of the two swaddling groups.
  • Follow the assigned swaddling technique as part of the infant's sleep routine for four weeks if allocated to a swaddling group.
  • Record the infant's sleep and crying durations daily for four weeks using a stopwatch and monitoring forms provided by the researchers.
  • Complete an assessment of maternal comfort at the beginning and end of the study.
  • Have the infant's body weight, length, and head circumference measured at the beginning and end of the study.
Read the detailed description

Swaddling is a commonly used infant care practice that may promote sleep and soothing when performed using safe techniques. However, inappropriate swaddling practices may restrict hip movement, contribute to overheating, or compromise safe sleep practices. Therefore, this study will compare two swaddling techniques designed to maintain infant safety while differing in positioning: hip-healthy swaddling and midline flexion swaddling.

This study is designed as a three-arm randomized controlled trial involving mothers and their infants aged 1-4 months attending the pediatric outpatient clinics of Izmir University of Economics Medical Point Hospital. A total of 96 mother-infant dyads are planned to be enrolled, with 32 dyads assigned to each group. Participants will be allocated to the hip-healthy swaddling group, midline flexion swaddling group, or control group using stratified block randomization according to infant age and sex.

In the hip-healthy swaddling group, mothers will be taught a swaddling technique that allows sufficient space for flexion and movement of the hips and knees while securely wrapping the upper body. In the midline flexion swaddling group, mothers will be taught a technique in which the infant's upper extremities are maintained close to the midline in a flexed position while the hips and knees remain flexed and sufficiently free to move. Both techniques will follow safe swaddling principles, including placing the infant supine, keeping the face and head uncovered, avoiding excessive tightness and overheating, and discontinuing swaddling when the infant shows signs of attempting to roll. The control group will continue routine infant care without a study-assigned swaddling intervention.

Mothers in both intervention groups will receive face-to-face instruction, an educational brochure, and an instructional video for the assigned technique. The intervention will be implemented for four weeks. Mothers will be contacted at least weekly during the intervention period to support adherence and safe implementation of the assigned technique.

Infant sleep and crying durations will be monitored daily throughout the four-week study period using standardized recording forms and stopwatches provided by the researchers. Maternal comfort will be evaluated using the General Comfort Questionnaire-Short Form at baseline and at the end of the intervention. Infant body weight, length, and head circumference will be measured at baseline and at the end of the four-week follow-up as secondary outcomes.

The primary comparison will evaluate differences among the three study groups in infant sleep duration, infant crying duration, and maternal comfort over the study period. Secondary analyses will evaluate changes in infant growth parameters.

02

Conditions studied

  • Infant Sleep and Crying

Browse trials for

Keywords

  • Swaddling
  • Infant Sleep
  • Infant Crying
  • Maternal Comfort
  • Infant Care
  • Hip-Healthy Swaddling
  • Midline Flexion Swaddling
03

In context

Crying

39 studies on the registry are indexed under Crying; 8 are open to participants now.

This study's planned enrollment of 96 is close to the median of 90 across 34 interventional studies indexed under Crying.

Browse Crying studies →

Lead sponsor

Izmir University of Economics is the lead sponsor of 22 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Month to 4 Months
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infants aged 1-4 months and their mothers.
  • Infants receiving outpatient care at the pediatric outpatient clinic.
  • Infants without anatomical, physiological, or developmental health conditions that would contraindicate swaddling, including developmental dysplasia of the hip, cardiopulmonary disorders, musculoskeletal disorders, or neurological disorders.
  • Infants who have not yet developed the ability to roll from the supine position to either side or to the prone position.
  • Mothers without a diagnosed physical or mental health condition severe enough to interfere with the daily care of their infant.
  • Mothers who provide written for participation.
  • Mothers who are able to speak and understand Turkish.

Exclusion criteria

Exclusion Criteria:

  • Infants who, during the study, are diagnosed with a condition for which swaddling is and who subsequently require pharmacological or physical treatment related to that condition.
  • Mothers who, during the study, begin pharmacological treatment with analgesic or sedative medications that may affect comfort.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
96 participants (estimated)

Study arms

  • Experimental
    Hip-Healthy Swaddling

    Mothers assigned to this group will receive face-to-face training on hip-healthy swaddling, supported by an educational brochure and instructional video. The technique securely wraps the infant's upper body while allowing sufficient space for the hips and knees to remain flexed and move freely. Mothers will use the assigned swaddling technique as part of the infant's sleep routine for four weeks.

    Behavioral: Hip-Healthy Swaddling

  • Experimental
    Midline Flexion Swaddling

    Mothers assigned to this group will receive face-to-face training on midline flexion swaddling, supported by an educational brochure and instructional video. The technique maintains the infant's upper extremities close to the midline in a flexed position while allowing the hips and knees to remain flexed and sufficiently free to move. Mothers will use the assigned swaddling technique as part of the infant's sleep routine for four weeks.

    Behavioral: Midline Flexion Swaddling

  • No intervention
    Routine Care Control

    Mother-infant dyads assigned to the control group will continue their routine infant care practices and will not receive a study-assigned swaddling intervention during the four-week study period.

Interventions

  • BehavioralHip-Healthy Swaddling

    Mothers assigned to this intervention will receive face-to-face training on hip-healthy swaddling, supported by an educational brochure and instructional video. The infant will be placed supine and the upper body will be securely wrapped, while sufficient space will be maintained around the hips and legs to allow hip abduction and flexion, knee flexion, and free movement of the lower extremities. The swaddle will allow approximately two-finger space at the chest, and the infant's face and head will remain uncovered. Mothers will apply the technique as part of the infant's sleep routine for four weeks. Safe swaddling principles, including avoiding excessive tightness and overheating, will be followed.

  • BehavioralMidline Flexion Swaddling

    Mothers assigned to this intervention will receive face-to-face training on midline flexion swaddling, supported by an educational brochure and instructional video. The infant will be placed supine, with the upper extremities maintained close to the midline in a flexed position. The hips and knees will remain flexed with sufficient space for free movement of the lower extremities. The swaddle will allow approximately two-finger space at the chest, and the infant's face and head will remain uncovered. Mothers will apply the technique as part of the infant's sleep routine for four weeks. Safe swaddling principles, including avoiding excessive tightness and overheating, will be followed.

06

What researchers measure

Primary outcomes

  1. Infant Sleep Duration

    Infant sleep duration will be recorded daily by mothers using a standardized sleep monitoring form and a stopwatch provided by the researchers. Mothers will start the stopwatch when the infant falls asleep and stop it when the infant wakes. Sleep duration will be recorded in minutes for each sleep episode, and daily total sleep duration will be calculated. Daily sleep durations will be recorded throughout the four-week follow-up period and summarized for analysis.

    Time frame: Daily for 4 weeks

  2. Infant Crying Duration

    Infant crying duration will be recorded daily by mothers using a standardized crying monitoring form and a stopwatch provided by the researchers. Mothers will start the stopwatch at the beginning of a crying episode and stop it when the crying episode ends. Crying duration will be recorded in minutes for each crying episode, and daily total crying duration will be calculated. Daily crying durations will be recorded throughout the four-week follow-up period and summarized for analysis.

    Time frame: Daily for 4 weeks

  3. Maternal Comfort

    Maternal comfort will be assessed using the General Comfort Questionnaire-Short Form. The scale consists of 28 items assessing relief, ease, and transcendence. After reverse coding negatively worded items, item scores are summed and divided by the number of items to obtain a mean score. Scores range from 1 to 6, with higher scores indicating a higher level of comfort.

    Time frame: Baseline and at the end of week 4

Secondary outcomes

  1. Change in Infant Body Weight

    Infant body weight will be measured using the same calibrated infant scale by the same researcher at baseline and at the end of the four-week follow-up. Body weight will be recorded in grams. Change in body weight from baseline to week 4 will be evaluated.

    Time frame: Baseline and at the end of week 4

  2. Change in Infant Length

    Infant length will be measured using the same infant length measurement equipment by the same researcher at baseline and at the end of the four-week follow-up. Length will be recorded in centimeters. Change in length from baseline to week 4 will be evaluated.

    Time frame: Baseline and at the end of week 4

  3. Change in Infant Head Circumference

    Infant head circumference will be measured using the same non-stretchable measuring tape by the same researcher at baseline and at the end of the four-week follow-up. Head circumference will be recorded in centimeters. Change in head circumference from baseline to week 4 will be evaluated.

    Time frame: Baseline and at the end of week 4

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the approved study protocol and informed consent procedures do not include sharing participant-level data with researchers outside the study team. Study findings will be reported only in aggregate form to protect participant confidentiality and privacy.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Aug 2027, 10 months later.

Of 15 interventional studies with no phase under Crying, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 10 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 5, 2026
First posted
Oct 9, 2026
StartEst.
Oct 2026
Primary completionEst.
Aug 2027
CompletionEst.
Aug 2027
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 9, 2026
Show all 2 updates
  1. Oct 13, 2026
    Minor edits only
    + 1 other change: criteria formatting
  2. Oct 9, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07868380
Lead sponsor
Izmir University of Economics
Collaborators
The Scientific and Technological Research Council of Turkey
Responsible party
Bahise Aydın (Associate Professor of Pediatric Nursing, Izmir University of Economics) — Principal investigator
First posted
Oct 9, 2026
Start date
Oct 2026 (estimated)
Primary completion
Aug 2027 (estimated)
Completion
Aug 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Bahise Aydın, PhD
Contact
bahise.aydin@ieu.edu.tr
05555210896
Bahise Aydın, PhD
principal investigator · İzmir University of Economics

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion